Nyxoah (NYXH) Competitors $7.77 +0.07 (+0.91%) Closing price 07/3/2025 12:59 PM EasternExtended Trading$7.57 -0.20 (-2.59%) As of 07/3/2025 04:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NYXH vs. PLSE, KMTS, INMD, MDXG, SIBN, IRMD, CBLL, BBNX, AVNS, and EMBCShould you be buying Nyxoah stock or one of its competitors? The main competitors of Nyxoah include Pulse Biosciences (PLSE), Kestra Medical Technologies (KMTS), InMode (INMD), MiMedx Group (MDXG), SiBone (SIBN), iRadimed (IRMD), CeriBell (CBLL), Beta Bionics (BBNX), Avanos Medical (AVNS), and Embecta (EMBC). These companies are all part of the "medical equipment" industry. Nyxoah vs. Its Competitors Pulse Biosciences Kestra Medical Technologies InMode MiMedx Group SiBone iRadimed CeriBell Beta Bionics Avanos Medical Embecta Nyxoah (NASDAQ:NYXH) and Pulse Biosciences (NASDAQ:PLSE) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability. Is NYXH or PLSE more profitable? Pulse Biosciences has a net margin of 0.00% compared to Nyxoah's net margin of -1,571.39%. Nyxoah's return on equity of -63.37% beat Pulse Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Nyxoah-1,571.39% -63.37% -46.67% Pulse Biosciences N/A -68.44%-58.17% Do institutionals and insiders believe in NYXH or PLSE? 77.0% of Pulse Biosciences shares are held by institutional investors. 17.1% of Nyxoah shares are held by insiders. Comparatively, 71.5% of Pulse Biosciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has preferable valuation & earnings, NYXH or PLSE? Pulse Biosciences has lower revenue, but higher earnings than Nyxoah. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNyxoah$4.89M54.12-$64.10M-$2.13-3.65Pulse Biosciences$700K1,421.90-$53.58MN/AN/A Which has more volatility & risk, NYXH or PLSE? Nyxoah has a beta of 1.62, suggesting that its stock price is 62% more volatile than the S&P 500. Comparatively, Pulse Biosciences has a beta of 1.56, suggesting that its stock price is 56% more volatile than the S&P 500. Do analysts prefer NYXH or PLSE? Nyxoah presently has a consensus target price of $14.50, suggesting a potential upside of 86.62%. Given Nyxoah's stronger consensus rating and higher possible upside, analysts clearly believe Nyxoah is more favorable than Pulse Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nyxoah 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Pulse Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media refer more to NYXH or PLSE? In the previous week, Pulse Biosciences had 1 more articles in the media than Nyxoah. MarketBeat recorded 1 mentions for Pulse Biosciences and 0 mentions for Nyxoah. Nyxoah's average media sentiment score of 0.00 equaled Pulse Biosciences'average media sentiment score. Company Overall Sentiment Nyxoah Neutral Pulse Biosciences Neutral SummaryNyxoah beats Pulse Biosciences on 7 of the 13 factors compared between the two stocks. Get Nyxoah News Delivered to You Automatically Sign up to receive the latest news and ratings for NYXH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NYXH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NYXH vs. The Competition Export to ExcelMetricNyxoahMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$264.65M$2.04B$5.55B$9.05BDividend YieldN/AN/A5.24%4.01%P/E Ratio-3.6535.8727.6120.23Price / Sales54.1215.98417.23118.52Price / CashN/A55.8836.8958.10Price / Book2.168.708.035.67Net Income-$64.10M-$62.39M$3.18B$249.21M7 Day Performance4.02%2.58%2.93%3.28%1 Month Performance0.78%3.01%3.75%5.55%1 Year Performance-0.67%4.06%35.20%21.09% Nyxoah Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NYXHNyxoah3.0196 of 5 stars$7.77+0.9%$14.50+86.6%+5.1%$264.65M$4.89M-3.65110PLSEPulse Biosciences0.7125 of 5 stars$15.09+0.1%N/A+28.2%$1.01B$700K0.00140News CoveragePositive NewsKMTSKestra Medical TechnologiesN/A$16.58-6.2%$27.50+65.9%N/A$907.33MN/A0.00300INMDInMode3.3636 of 5 stars$14.44+1.8%$18.54+28.4%-13.3%$896.94M$394.82M6.20480MDXGMiMedx Group3.4441 of 5 stars$6.11+2.9%$12.50+104.6%-7.8%$877.35M$348.88M22.63870SIBNSiBone4.1653 of 5 stars$18.82+2.1%$22.50+19.6%+41.6%$785.39M$167.18M-29.41350IRMDiRadimed4.6897 of 5 stars$59.79-1.7%$72.00+20.4%+40.6%$773.59M$73.24M38.57110Positive NewsCBLLCeriBell2.0954 of 5 stars$18.73-0.9%$32.14+71.6%N/A$683.10M$65.44M0.00N/ABBNXBeta BionicsN/A$14.56-3.4%$23.44+61.0%N/A$653.38M$65.12M0.00294AVNSAvanos MedicalN/A$12.25+0.3%N/A-36.4%$564.64M$689.20M-1.462,227EMBCEmbecta4.1447 of 5 stars$9.69+0.5%$19.33+99.5%-14.5%$563.39M$1.12B10.772,100 Related Companies and Tools Related Companies Pulse Biosciences Competitors Kestra Medical Technologies Competitors InMode Competitors MiMedx Group Competitors SiBone Competitors iRadimed Competitors CeriBell Competitors Beta Bionics Competitors Avanos Medical Competitors Embecta Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NYXH) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nyxoah SA Please log in to your account or sign up in order to add this asset to your watchlist. Share Nyxoah With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NYXH Stock Alerts